- Home
- REPL vs ORRF Comparison
REPL vs ORRF Comparison
Compare REPL & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- ORRF
- Stock Information
- Founded
- REPL 2015
- ORRF 1919
- Country
- REPL United States
- ORRF United States
- Employees
- REPL N/A
- ORRF N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- ORRF Major Banks
- Sector
- REPL Health Care
- ORRF Finance
- Exchange
- REPL Nasdaq
- ORRF Nasdaq
- Market Cap
- REPL 578.4M
- ORRF 514.4M
- IPO Year
- REPL 2018
- ORRF N/A
- Fundamental
- Price
- REPL $7.71
- ORRF $30.44
- Analyst Decision
- REPL Strong Buy
- ORRF Buy
- Analyst Count
- REPL 6
- ORRF 3
- Target Price
- REPL $20.00
- ORRF $34.50
- AVG Volume (30 Days)
- REPL 1.1M
- ORRF 175.8K
- Earning Date
- REPL 05-19-2025
- ORRF 04-22-2025
- Dividend Yield
- REPL N/A
- ORRF 3.42%
- EPS Growth
- REPL N/A
- ORRF N/A
- EPS
- REPL N/A
- ORRF 1.84
- Revenue
- REPL N/A
- ORRF $203,869,000.00
- Revenue This Year
- REPL $31.16
- ORRF $17.74
- Revenue Next Year
- REPL N/A
- ORRF $8.71
- P/E Ratio
- REPL N/A
- ORRF $16.52
- Revenue Growth
- REPL N/A
- ORRF 56.29
- 52 Week Low
- REPL $4.92
- ORRF $24.91
- 52 Week High
- REPL $17.00
- ORRF $41.99
- Technical
- Relative Strength Index (RSI)
- REPL 39.21
- ORRF 62.03
- Support Level
- REPL $6.93
- ORRF $29.57
- Resistance Level
- REPL $10.30
- ORRF $29.81
- Average True Range (ATR)
- REPL 0.73
- ORRF 0.78
- MACD
- REPL -0.07
- ORRF 0.32
- Stochastic Oscillator
- REPL 23.15
- ORRF 94.92
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.